Literature DB >> 21190492

The disappearance of subpleural and interlobular lymphatics in idiopathic pulmonary fibrosis.

Masahito Ebina1, Naoko Shibata, Hiromitsu Ohta, Shu Hisata, Tsutomu Tamada, Masao Ono, Kenta Okaya, Takashi Kondo, Toshihiro Nukiwa.   

Abstract

BACKGROUND: The lymphatics in the interlobular and subpleural parenchyma contribute to alveolar clearance in the lung, but the information on the remodeling of these lymphatics is quite limited in idiopathic pulmonary fibrosis lungs that contain severe fibrosis in these regions. We compared the alteration of these lymphatics and lymphangiogenesis among idiopathic pulmonary fibrosis and nonfibrotic interstitial pneumonias with a better prognosis. METHODS AND
RESULTS: The lung tissue specimens of eighteen patients with idiopathic pulmonary fibrosis (ten surgical biopsies and eight autopsies), six with organizing pneumonia, six with cellular nonspecific interstitial pneumonia, and five normal controls were examined by morphometric analysis of the lymphatics identified by immunohistochemistry. In addition, three-dimensional reconstruction of lymphatics, apoptosis of lymphatic endothelial cells and the cells producing growth factors for lymphangiogenesis were also evaluated. Both the subpleural and the interlobular lymphatics in idiopathic pulmonary fibrosis lungs were significantly decreased in the severe fibroconnective lesions, with rare lymphangiogenesis. The three-dimensional images of the subpleural lymphatics in idiopathic pulmonary fibrosis clearly revealed destruction by fibrosis; apoptosis was observed in these lymphatic endothelial cells. In contrast, organizing pneumonia and cellular nonspecific interstitial pneumonia preserved these lymphatics, and active lymphangiogenesis occurred in the alveolar lesions.
CONCLUSIONS: These results reveal severe damage of the subpleural and interlobular lymphatics in idiopathic pulmonary fibrosis lungs, and suggest impaired alveolar clearance as another pathogenesis of its refractoriness.

Entities:  

Mesh:

Year:  2010        PMID: 21190492     DOI: 10.1089/lrb.2010.0008

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  17 in total

1.  Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung.

Authors:  Francesca Sozio; Antonella Rossi; Elisabetta Weber; David J Abraham; Andrew G Nicholson; Athol U Wells; Elisabetta A Renzoni; Piersante Sestini
Journal:  J Anat       Date:  2012-01-30       Impact factor: 2.610

Review 2.  Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?

Authors:  Benjamin Stump; Ye Cui; Pranav Kidambi; Anthony M Lamattina; Souheil El-Chemaly
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

3.  Increased lymphatic vessel length is associated with the fibroblast reticulum and disease severity in usual interstitial pneumonia and nonspecific interstitial pneumonia.

Authors:  Abigail R Lara; Gregory P Cosgrove; William J Janssen; Tristan J Huie; Ellen L Burnham; David E Heinz; Douglas Curran-Everett; Hakan Sahin; Marvin I Schwarz; Carlyne D Cool; Steve D Groshong; Mark W Geraci; Rubin M Tuder; Dallas M Hyde; Peter M Henson
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

4.  Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation.

Authors:  Peter Baluk; Alicia Adams; Keeley Phillips; Jennifer Feng; Young-Kwon Hong; Mary B Brown; Donald M McDonald
Journal:  Am J Pathol       Date:  2014-03-11       Impact factor: 4.307

5.  Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury.

Authors:  Peter Baluk; Ram P Naikawadi; Shineui Kim; Felipe Rodriguez; Dongwon Choi; Young-Kwon Hong; Paul J Wolters; Donald M McDonald
Journal:  Am J Pathol       Date:  2020-10-08       Impact factor: 4.307

6.  Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis.

Authors:  Anna-Katharina Meinecke; Nadine Nagy; Gabriela D'Amico Lago; Santina Kirmse; Ralph Klose; Katrin Schrödter; Annika Zimmermann; Iris Helfrich; Helene Rundqvist; Dirk Theegarten; Olaf Anhenn; Véronique Orian-Rousseau; Randall S Johnson; Kari Alitalo; Jens W Fischer; Joachim Fandrey; Christian Stockmann
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

7.  Radiation-induced impairment in lung lymphatic vasculature.

Authors:  Ye Cui; Julie Wilder; Cecilia Rietz; Andrew Gigliotti; Xiaomeng Tang; Yuanyuan Shi; Raymond Guilmette; Hao Wang; Gautam George; Eduarda Nilo de Magaldi; Sarah G Chu; Melanie Doyle-Eisele; Jacob D McDonald; Ivan O Rosas; Souheil El-Chemaly
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

Review 8.  Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.

Authors:  Connie G Glasgow; Souheil El-Chemaly; Joel Moss
Journal:  Eur Respir Rev       Date:  2012-09-01

9.  Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis.

Authors:  Lisa M Kaminskas; Cornelia B Landersdorfer; Robert J Bischof; Nathania Leong; Jibriil Ibrahim; Andrew N Davies; Stephen Pham; Steven Beck; A Bruce Montgomery; Mark W Surber
Journal:  Pharm Res       Date:  2019-12-10       Impact factor: 4.200

10.  Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer.

Authors:  Tomohiro Maniwa; Mitsuhiro Isaka; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Masahiro Endo; Haruhiko Kondo
Journal:  Surg Today       Date:  2012-11-24       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.